North America Healthcare Contract Research Organizations (CRO) Services Market Forecast to 2027 - COVID-19 Impact and Regional Analysis byService Type (Early Phase Development, Laboratory Services, Consulting Services, Clinical Research Services); Therapeutic Indication (Oncology, Infectious Diseases, Respiratory Diseases, Cardiovascular Diseases, Neurological Disorders, Others); End User (Medical Device Companies, Pharmaceutical and Biopharmaceutical Companies, Others (Academic Institutes), and Country

TIPRE00012990 | Pages: 168 | Pharmaceuticals | Aug 2020 | Type: Regional | Status: Published

Market Introduction

Healthcare contract research organization generally assists biotechnology, medical device, and pharmaceutical companies in the form of research services outsourced on a contract basis. Secured services include preclinical and clinical testing, clinical research, product development such as drug development or process development such as bioanalytical assay development. These organizations also provide management services such as clinical trial management and pharmacovigilance.


Get more information on this report :



Market Overview and Dynamics

The North America healthcare contract research organizations (CRO) services market is to reach US$ 40,863.26 million by 2027 from US$ 19,498.79 million in 2019. The market is anticipated to grow at a CAGR of 9.9% during 2019–2027. Factors such as growing number of clinical trials and increasing expenditure in R&D and outsourcing activities are driving the growth of the market. However, stringent regulations for approval of drugs is a major factor hindering the market growth.

Key Market Segments

In terms of service type, the clinical research services segment accounted for the largest share of the North America healthcare contract research organizations (CRO) services market in 2019. Oncology segment accounted for the largest share of the North America healthcare contract research organizations (CRO) services market, by therapeutic indication, in 2019. In terms of end-user, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the North America Healthcare contract research organizations (CRO) services market in 2019.

Major Sources and Companies Listed

Several major primary and secondary sources associated with the North America healthcare contract research organizations (CRO) services market report are the World Health Organization (WHO), National Institutes of Health (NIH), National Cancer Institute, Centers for Disease Control and Prevention (CDC), Asthma and Allergy Foundation of America (AAFA), and others.

Reasons to buy report

  • It provides understanding of the North America, healthcare contract research organizations (CRO) services market landscape and identifies healthcare contract research organizations (CRO) services market segments that are most likely to guarantee a strong return.
  • It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the North America healthcare contract research organizations (CRO) services market.
  • It helps efficiently plan merger and acquisition, and partnership deals in the healthcare contract research organizations (CRO) services market by identifying market segments with the most promising probable sales
  • It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of healthcare contract research organizations (CRO) services market performance of various segments pertaining to the North America healthcare contract research organizations (CRO) services market.
  • It provides healthcare contract research organizations (CRO) services market revenue forecast of the market based on various segments for the period from 2019 to 2027.

NORTH AMERICA HEALTHCARE CONTRACT RESEARCH ORGANIZATIONS (CRO) SERVICES MARKET SEGMENTATION

By Service Type

  • Early Phase Development
  • Laboratory Services
  • Consulting Services
  • Clinical Research Services

 

By Therapeutic Application

  • Oncology
  • Infectious Diseases
  • Respiratory Diseases
  • Cardiovascular Diseases
  • Neurological Disorders
  • Others

By End-User

  • Medical Device Companies
  • Pharmaceutical and Biopharmaceutical Companies
  • Others (Academic Institutes)

By Country

  • US
  • Canada
  • Mexico

 

Company Profiles

  • Charles River Laboratories, Inc.
  • IQVIA INC
  • Laboratory Corporation of America Holdings (Covance)
  • Parexel International Corporation
  • PRA Health Sciences
  • Syneos Health
  • Medpace
  • PPD Inc

1.           Introduction. 21

1.1         Scope of the Study. 21

1.2         The Insight Partners Research Report Guidance. 21

1.3         Market Segmentation. 23

1.3.1        North America Healthcare contract research organizations (CRO) services Market – By Service Type. 24

1.3.2        North America Healthcare contract research organizations (CRO) services Market – By Therapeutic Indication. 24

1.3.3        North America Healthcare contract research organizations (CRO) services Market – By End User 25

1.3.4        North America Healthcare contract research organizations (CRO) services Market – By Country. 25

2.           North America Healthcare contract research organizations (CRO) services Market –  Key Takeaways. 26

3.           Research Methodology. 30

3.1         Coverage. 31

3.2         Secondary Research. 32

3.3         Primary Research. 33

4.           North America Healthcare contract research organizations (CRO) services Market – Market Landscape. 34

4.1         Overview.. 34

4.2         PEST Analysis. 35

4.2.1        Healthcare contract research organizations (CRO) services Market - North America PEST Analysis. 35

4.3         Expert Opinion. 36

5.           North America Healthcare Contract Research Organizations (CRO) services Market - Key Market Dynamics. 37

5.1         Key Market Drivers. 37

5.1.1        Increasing Expenditure in R&D and Outsourcing Activities. 37

5.1.1        Rising Number of Clinical Trials. 38

5.2         Key Market Restraints. 39

5.2.1        Stringent Regulations For Approval Of Drugs. 39

5.3         Key Market Opportunities. 39

5.3.1        Rising Biosimilars and Biologics Market 39

5.4         Future Trends. 41

5.4.1        Globalization of Clinical Studies. 41

5.5         Impact Analysis. 42

6.           Healthcare Contract Research Organizations (CRO) Services Market – North America Analysis. 43

6.1         North America Healthcare Contract Research Organizations (CRO) Services Market Revenue Forecasts and Analysis. 43

7.           North America Healthcare Contract Research Organizations (CRO) Services Market Analysis and Forecasts To 2027 – By Service Type. 44

7.1         Overview.. 44

7.2         North America Healthcare Contract Research Organizations (CRO) Services market, By Service Type 2019 & 2027 (%) 44

7.2.1        North America Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027, By Service Type (US$ Mn) 45

7.2.2        Clinical-Research Services Market Revenue and Forecasts to 2027 (US$ Million) 46

7.2.3        Early Phase Development Market Revenue and Forecasts to 2027 (US$ Million) 47

7.2.4        Laboratory Services Market Revenue and Forecasts to 2027 (US$ Million) 47

7.3         Early Phase Development 48

7.3.1        Overview.. 48

7.3.2        North America Early Phase Development Market Revenue and Forecast to 2027 (US$ Mn) 48

7.3.3        Discovery Studies. 49

7.3.3.1          Overview.. 49

7.3.3.2          North America Discovery Studies Market Revenue and Forecasts to 2027 (US$ Mn) 49

7.3.4        Chemistry, Manufacturing, and Control 51

7.3.4.1          Overview.. 51

7.3.4.2          North America Chemistry, Manufacturing, and Control Market Revenue and Forecasts to 2027 (US$ Mn) 51

7.3.5        Pre-Clinical Services. 53

7.3.5.1          Overview.. 53

7.3.5.2          North America Pre-Clinical Services Market Revenue and Forecasts to 2027 (US$ Mn) 53

7.4         Laboratory Services. 55

7.4.1        Overview.. 55

7.4.2        North America Laboratory Services Market Revenue and Forecasts to 2027 (US$ Mn) 55

7.4.3        Bio-analytical Testing. 56

7.4.3.1          Overview.. 56

7.4.3.2          North America Bio-analytical Testing Market Revenue and Forecasts to 2027 (US$ Mn) 56

7.4.4        Analytical Testing. 57

7.4.4.1          Overview.. 57

7.4.4.2          North America Analytical Testing Market Revenue and Forecasts to 2027 (US$ Mn) 57

7.5         Consulting Services. 58

7.5.1        Overview.. 58

7.5.2        North America Consulting Services Market Revenue and Forecasts to 2027 (US$ Mn) 58

7.6         Clinical Research Services. 59

7.6.1        Overview.. 59

7.6.2        North America Clinical Research Services Market Revenue and Forecasts to 2027 (US$ Mn) 59

7.6.3        Phase I 61

7.6.3.1          Overview.. 61

7.6.3.2          North America Phase I Market Revenue and Forecasts to 2027 (US$ Mn) 61

7.6.4        Phase II 62

7.6.4.1          Overview.. 62

7.6.4.2          North America Phase II Market Revenue and Forecasts to 2027 (US$ Mn) 62

7.6.5        Phase III 63

7.6.5.1          Overview.. 63

7.6.5.2          North America Phase III Market Revenue and Forecasts to 2027 (US$ Mn) 63

7.6.6        Phase IV. 64

7.6.6.1          Overview.. 64

7.6.6.2          North America Phase IV Market Revenue and Forecasts to 2027 (US$ Mn) 64

8.           North America Healthcare Contract Research Organizations (CRO) Services Market Analysis –  By Therapeutic Application. 65

8.1         Overview.. 65

8.2         North America Healthcare Contract Research Organizations (CRO) Services Market, By Therapeutic Application 2019-2027 (%) 65

8.2.1        North America Healthcare Contract Research Organizations (CRO) Services Market Devices Revenue and Forecasts to 2027, By Therapeutic Application (US$ Mn) 67

8.3         Oncology. 68

8.3.1        Overview.. 68

8.3.2        North America Oncology Market Revenue and Forecasts to 2027 (US$ Mn) 68

8.4         Infectious Diseases. 70

8.4.1        Overview.. 70

8.4.2        North America Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn) 70

8.5         Cardiovascular Disease. 71

8.5.1        Overview.. 71

8.5.2        North America Cardiovascular Disease Market Revenue and Forecasts to 2027 (US$ Mn) 71

8.6         Respiratory Diseases. 73

8.6.1        Overview.. 73

8.6.2        North America Respiratory Diseases Market Revenue and Forecasts to 2027 (US$ Mn) 73

8.7         Neurological Disorders. 75

8.7.1        Overview.. 75

8.7.2        North America Neurological Disorders Market Revenue and Forecasts to 2027 (US$ Mn) 75

8.8         Others. 77

8.8.1        Overview.. 77

8.8.2        North America Others Market Revenue and Forecasts to 2027 (US$ Mn) 78

9.           North America Healthcare contract research organizations (CRO) services Market Analysis –  By End User. 79

9.1         Overview.. 79

9.2         North America Healthcare contract research organizations (CRO) services Market, By End User 2019-2027 (%) 79

9.2.1        North America Healthcare contract research organizations (CRO) services Market Revenue and Forecasts to 2027, By End User (US$ Mn) 81

9.3         Pharmaceutical and Biopharmaceutical Companies. 82

9.3.1        Overview.. 82

9.3.2        North America Pharmaceutical and Biopharmaceutical Companies Market Revenue and Forecasts to 2027 (US$ Mn) 82

9.4         Medical Device Companies. 84

9.4.1        Overview.. 84

9.4.2        North America Medical Device Companies Market Revenue and Forecasts to 2027 (US$ Mn) 84

9.5         Others (Academic Institutes) 85

9.5.1        Overview.. 85

9.5.2        North America Others (Academic Institutes) Market Revenue and Forecasts to 2027 (US$ Mn) 85

10.        Healthcare contract research organizations (CRO) services Market Revenue and Forecasts To 2027 – Geographical Analysis. 86

10.1      North America Healthcare contract research organizations (CRO) services Market Revenue and Forecasts To 2027. 86

10.1.1     Overview.. 86

10.1.2     North America: Healthcare Contract Research Organizations (CRO) Services Market-Revenue and Forecasts to 2027 (US$ Million) 88

10.1.3     North America Healthcare Contract Research Organizations (CRO) Services Market, by Service Type – Revenue and Forecast to 2027  (USD Million) 89

10.1.3.1       North America Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services – Revenue and Forecast to 2027 (USD Million) 90

10.1.3.2       North America Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million) 91

10.1.3.3       North America Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 91

10.1.4     North America Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication – Revenue and Forecast to 2027 (USD Million) 92

10.1.5     North America Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million) 93

10.1.6     North America: Healthcare Contract Research Organizations (CRO) Services Market, by Country, 2019 & 2027 (%) 94

10.1.7     US Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 95

10.1.7.1       US Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 96

10.1.8     US Healthcare Contract Research Organizations (CRO) Services Market, by Service Type – Revenue and Forecast to 2027 (USD Million) 96

10.1.8.1       US Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services – Revenue and Forecast to 2027 (USD Million) 97

10.1.8.2       US Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million) 98

10.1.8.3       US Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 99

10.1.9     US Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication – Revenue and Forecast to 2027  (USD Million) 100

10.1.10  US Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million) 101

10.1.11  Canada Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 102

10.1.11.1    Canada Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 103

10.1.12  Canada Healthcare Contract Research Organizations (CRO) Services Market, by Service Type – Revenue and Forecast to 2027  (USD Million) 104

10.1.12.1    Canada Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services – Revenue and Forecast to 2027  (USD Million) 105

10.1.12.2    Canada Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027  (USD Million) 106

10.1.12.3    Canada Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 106

10.1.13  Canada Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication – Revenue and Forecast to 2027 (USD Million) 107

10.1.14  Canada Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million) 108

10.1.15  Mexico Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 109

10.1.15.1    Mexico Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 110

10.1.16  Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Service Type – Revenue and Forecast to 2027  (USD Million) 111

10.1.16.1    Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services – Revenue and Forecast to 2027  (USD Million) 112

10.1.16.2    Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027  (USD Million) 112

10.1.16.3    Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 113

10.1.17  Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Indication – Revenue and Forecast to 2027 (USD Million) 114

10.1.18  Mexico Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million) 115

11.        Impact of COVID-19 Pandemic on North America Healthcare contract research organizations (CRO) services Market 116

11.1      North America: Impact Assessment of COVID-19 Pandemic. 116

12.        Company Profiles. 118

12.1      Charles River Laboratories, Inc. 118

12.1.1     Key Facts. 118

12.1.2     Business Description. 118

12.1.3     Products and Services. 119

12.1.4     Financial Overview.. 120

12.1.5     SWOT Analysis. 122

12.1.6     Key Developments. 123

12.2      IQVIA INC. 125

12.2.1     Key Facts. 125

12.2.2     Business Description. 125

12.2.3     Products and Services. 126

12.2.4     Financial Overview.. 127

12.2.5     SWOT Analysis. 129

12.2.6     Key Developments. 130

12.3      Laboratory Corporation of America Holdings(Covance) 131

12.3.1     Key Facts. 131

12.3.2     Business Description. 131

12.3.3     Products and Services. 132

12.3.4     Financial Overview.. 133

12.3.5     SWOT Analysis. 135

12.3.6     Key Developments. 136

12.4      Parexel International Corporation. 137

12.4.1     Key Facts. 137

12.4.2     Business Description. 137

12.4.3     Products and Services. 138

12.4.4     Financial Overview.. 138

12.4.5     SWOT Analysis. 139

12.4.6     Key Developments. 140

12.5      PRA Health Sciences. 141

12.5.1     Key Facts. 141

12.5.2     Business Description. 141

12.5.3     Products and Services. 142

12.5.4     Financial Overview.. 142

12.5.5     SWOT Analysis. 144

12.5.6     Key Developments. 145

12.6      Syneos Health. 146

12.6.1     Key Facts. 146

12.6.2     Business Description. 146

12.6.3     Products and Services. 147

12.6.4     Financial Overview.. 148

12.6.5     SWOT Analysis. 150

12.6.6     Key Developments. 151

12.7      Medpace. 152

12.7.1     Key Facts. 152

12.7.2     Business Description. 152

12.7.3     Products and Services. 153

12.7.4     Financial Overview.. 153

12.7.5     SWOT Analysis. 155

12.7.6     Key Developments. 155

12.8      PPD Inc. 156

12.8.1     Key Facts. 156

12.8.2     Business Description. 156

12.8.3     Products and Services. 157

12.8.4     Financial Overview.. 157

12.8.5     SWOT Analysis. 159

12.8.6     Key Developments. 160

13.        Appendix. 161

13.1      About The Insight Partners. 161

13.2      Glossary of Terms. 161

LIST OF TABLES

Table 1.             Number of registered Studies For Clinical Trials. 38

Table 2.             North America Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts To 2027, By Service Type (US$ Mn) 46

Table 3.             Clinical-Research Services Market Revenue And Forecasts to 2027 (US$ Million) 46

Table 4.             Early Phase Development Market Revenue And Forecasts to 2027 (US$ Million) 47

Table 5.             Laboratory Services Market Revenue And Forecasts to 2027 (US$ Million) 47

Table 6.             North America Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts To 2027, By Therapeutic Application (US$ Mn) 67

Table 7.             North America Healthcare contract research organizations (CRO) services Market Revenue and Forecasts To 2027, By End User  (US$ Mn) 81

Table 8.             North America Healthcare Contract Research Organizations (CRO) Services Market, by Service Type– Revenue and Forecast to 2027 (USD Million) 89

Table 9.             North America Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services– Revenue and Forecast to 2027 (USD Million) 90

Table 10.          North America Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million) 91

Table 11.          North America Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 91

Table 12.          North America Healthcare Contract Research Organizations (CRO) Services, by Therapeutic Indication– Revenue and Forecast to 2027 (USD Million) 92

Table 13.          North America Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027  (USD Million) 93

Table 14.          US Healthcare Contract Research Organizations (CRO) Services Market, by Service Type– Revenue and Forecast to 2027 (USD Million) 97

Table 15.          US Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services– Revenue and Forecast to 2027 (USD Million) 97

Table 16.          US Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million) 98

Table 17.          US Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 99

Table 18.          US Healthcare Contract Research Organizations (CRO) Services, by Therapeutic Indication– Revenue and Forecast to 2027  (USD Million) 100

Table 19.          US Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million) 101

Table 20.          Canada Healthcare Contract Research Organizations (CRO) Services Market, by Service Type– Revenue and Forecast to 2027  (USD Million) 104

Table 21.          Canada Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services– Revenue and Forecast to 2027 (USD Million) 105

Table 22.          Canada Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million) 106

Table 23.          Canada Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 106

Table 24.          Canada Healthcare Contract Research Organizations (CRO) Services, by Therapeutic Indication– Revenue and Forecast to 2027  (USD Million) 107

Table 25.          Canada Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027  (USD Million) 108

Table 26.          Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Service Type– Revenue and Forecast to 2027  (USD Million) 111

Table 27.          Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Clinical Research Services– Revenue and Forecast to 2027 (USD Million) 112

Table 28.          Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Early Phase Development – Revenue and Forecast to 2027 (USD Million) 112

Table 29.          Mexico Healthcare Contract Research Organizations (CRO) Services Market, by Laboratory Services – Revenue and Forecast to 2027 (USD Million) 113

Table 30.          Mexico Healthcare Contract Research Organizations (CRO) Services, by Therapeutic Indication– Revenue and Forecast to 2027 (USD Million) 114

Table 31.          Mexico Healthcare Contract Research Organizations (CRO) Services Market, by End User – Revenue and Forecast to 2027 (USD Million) 115

Table 32.          Glossary of Terms, Healthcare Contract Research Organizations (CRO) Services Market 161

 

 

LIST OF FIGURES

Figure 1.           Healthcare contract research organizations (CRO) services Market Segmentation. 23

Figure 2.           North America Healthcare contract research organizations (CRO) services Market Overview.. 26

Figure 3.           Clinical Research Services Segment Held Largest Share of Healthcare Contract Research Organizations (CRO) Services Market 27

Figure 4.           US is Expected to Show Remarkable Growth During the Forecast Period. 28

Figure 5.           North America Healthcare contract research organizations (CRO) services Market - Leading Country Markets (US$ Mn) 29

Figure 6.           Healthcare contract research organizations (CRO) services Market - North America PEST Analysis. 35

Figure 1.           Number of Approvals for NDA and BLA (2005 to 2019) 40

Figure 2.           Healthcare contract research organizations (CRO) services Market Impact Analysis of Driver and Restraints. 42

Figure 3.           North America Healthcare Contract Research Organizations (CRO) Services market – Revenue Forecasts and Analysis – 2019- 2027. 43

Figure 4.           North America Healthcare Contract Research Organizations (CRO) Services market, By Service Type 2019 & 2027 (%) 45

Figure 5.           North America Early Phase Development Market Revenue and Forecasts to 2027 (US$ Mn) 48

Figure 6.           North America Discovery Studies Market Revenue and Forecasts to 2027 (US$ Mn) 50

Figure 7.           North America Chemistry, Manufacturing, and Control Market Revenue and Forecasts to 2027 (US$ Mn) 52

Figure 8.           North America Pre-Clinical Services Market Revenue and Forecasts to 2027 (US$ Mn) 54

Figure 9.           North America Laboratory Services Market Revenue and Forecasts to 2027 (US$ Mn) 55

Figure 10.        North America Bio-analytical Testing Market Revenue and Forecasts to 2027 (US$ Mn) 56

Figure 11.        North America Analytical Testing Market Revenue and Forecasts to 2027 (US$ Mn) 57

Figure 12.        North America Consulting Services Market Revenue and Forecasts to 2027 (US$ Mn) 58

Figure 13.        North America Clinical Research Services Market Revenue and Forecasts to 2027 (US$ Mn) 60

Figure 14.        North America Phase I Market Revenue and Forecasts to 2027 (US$ Mn) 61

Figure 15.        North America Phase II Market Revenue and Forecasts to 2027 (US$ Mn) 62

Figure 16.        North America Phase II Market Revenue and Forecasts to 2027 (US$ Mn) 63

Figure 17.        North America Phase IV Market Revenue and Forecasts to 2027 (US$ Mn) 64

Figure 18.        North America Healthcare Contract Research Organizations (CRO) Services Market, by Therapeutic Application 2019 & 2027 (%) 66

Figure 19.        North America Oncology Market Revenue and Forecasts to 2027 (US$ Mn) 69

Figure 20.        North America Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn) 70

Figure 21.        North America Cardiovascular Disease Market Revenue and Forecasts to 2027 (US$ Mn) 72

Figure 22.        North America Respiratory Diseases Market Revenue and Forecasts to 2027 (US$ Mn) 74

Figure 23.        North America Neurological Diseases Market Revenue and Forecasts to 2027 (US$ Mn) 76

Figure 24.        North America Others Market Revenue and Forecasts to 2027 (US$ Mn) 78

Figure 25.        North America Healthcare contract research organizations (CRO) services Market, by End User 2019 & 2027 (%) 80

Figure 26.        North America Pharmaceutical and Biopharmaceutical Companies Market Revenue and Forecasts to 2027 (US$ Mn) 83

Figure 27.        North America Medical Device Companies Market Revenue and Forecasts to 2027 (US$ Mn) 84

Figure 28.        North America Others (Academic Institutes) Market Revenue and Forecasts to 2027 (US$ Mn) 85

Figure 29.        North America Healthcare Contract Research Organizations (CRO) Services Market Revenue, by Country, 2019 (US$ Mn) 87

Figure 30.        North America Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Million) 88

Figure 31.        North America: Healthcare Contract Research Organizations (CRO) Services Market, by Country, 2019 & 2027 (%) 94

Figure 32.        US Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 96

Figure 33.        Canada Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 103

Figure 34.        Mexico Healthcare Contract Research Organizations (CRO) Services Market Revenue and Forecasts to 2027 (US$ Mn) 110

Figure 35.        Impact of COVID-19 Pandemic in North American Country Markets. 117

 

 

  1. Charles River Laboratories, Inc.
  2. IQVIA INC
  3. Laboratory Corporation of America Holdings (Covance)
  4. Parexel International Corporation
  5. PRA Health Sciences
  6. Syneos Health
  7. Medpace
  8. PPD Inc
  • It provides understanding of the North America, healthcare contract research organizations (CRO) services market landscape and identifies healthcare contract research organizations (CRO) services market segments that are most likely to guarantee a strong return.
  • It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the North America healthcare contract research organizations (CRO) services market.
  • It helps efficiently plan merger and acquisition, and partnership deals in the healthcare contract research organizations (CRO) services market by identifying market segments with the most promising probable sales
  • It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of healthcare contract research organizations (CRO) services market performance of various segments pertaining to the North America healthcare contract research organizations (CRO) services market.
  • It provides healthcare contract research organizations (CRO) services market revenue forecast of the market based on various segments for the period from 2019 to 2027.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000